Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia

被引：69
|
作者：
Zugmaier, G. [1 ]
Topp, M. S. [2 ,3 ]
Alekar, S. [4 ]
Viardot, A. [5 ]
Horst, H-A [6 ,7 ]
Neumann, S. [6 ,7 ]
Stelljes, M. [8 ]
Bargou, R. C. [3 ]
Goebeler, M. [3 ]
Wessiepe, D. [9 ]
Degenhard, E. [1 ]
Goekbuget, N. [10 ]
Klinger, M. [1 ]
机构：
[1] Amgen Res Munich GmbH, Munich, Germany
[2] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[3] Univ Klinikum Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
[5] Univ Ulm, Dept Med 3, D-89069 Ulm, Germany
[6] City Hosp, Dept Med 2, Kiel, Germany
[7] Univ Hosp Schleswig Holstein, Kiel, Germany
[8] Univ Munster, Bone Marrow Transplantat Ctr, D-48149 Munster, Germany
[9] Metronomia GmbH, Munich, Germany
[10] Goethe Univ Frankfurt, Ctr Internal Med, Frankfurt, Germany
来源：
BLOOD CANCER JOURNAL | 2014年 / 4卷
关键词：
STEM-CELL TRANSPLANTATION; ENGAGING ANTIBODY; FREE SURVIVAL; RITUXIMAB; LYMPHOMA; HYPOGAMMAGLOBULINEMIA; LINEAGE;
D O I：
10.1038/bcj.2014.64
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e244 / e244
页数：4
相关论文
共 50 条
  • [41] INFLUENCE OF BASELINE FACTORS ON OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (R/R ALL) TREATED WITH BLINATUMOMAB
    Topp, M. S.
    Goekbuget, N.
    O'Brien, S.
    Stein, A.
    Jia, C.
    Forman, S. J.
    Bargou, R.
    Fielding, A. K.
    Heffner, L. T., Jr.
    Larson, R. A.
    Neumann, S.
    Maniar, T.
    Nagorsen, D.
    Kantarjian, H.
    HAEMATOLOGICA, 2015, 100 : 30 - 30
  • [42] Short-Term Follow-up of Blinatumomab in Children with B-Cell Precursor Acute Lymphoblastic Leukemia:Study of a Single Center from China
    Yang, Wenyu
    Li, Xiaolan
    Liu, Li-Peng
    Wan, Yang
    Liu, Tianfeng
    Zhao, Bei-bei
    Ruan, Min
    Qi, Benquan
    Chen, Xia
    Liu, Fang
    Ren, Yuanyuan
    Zhang, Li
    Zou, Yao
    Chen, Yumei
    Chen, Xiaojuan
    Guo, Ye
    Zhu, Xiaofan
    BLOOD, 2022, 140 : 13214 - 13215
  • [43] The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: A long-term follow-up study
    Matutes, E
    Meeus, P
    McLennan, K
    Catovsky, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) : 375 - 383
  • [44] Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia
    Rambaldi, Alessandro
    Ribera, Josep-Maria
    Kantarjian, Hagop M.
    Dombret, Herve
    Ottmann, Oliver G.
    Stein, Anthony S.
    Tuglus, Catherine A.
    Zhao, Xiaoyue
    Kim, Christopher
    Martinelli, Giovanni
    CANCER, 2020, 126 (02) : 304 - 310
  • [45] Reduction of minimal residual disease in pediatric B-precursor acute lymphoblastic leukemia by an Fc-optimized CD19 antibody
    Seidel, Ursula Joerdis Eva
    Grosse-Hovest, Ludger
    Schlegel, Patrick
    Hofmann, Martin
    Schuster, Friedhelm R.
    Meisel, Roland
    Witte, Kai-Erik
    Aulwurm, Steffen
    Pyz, Elwira
    Rammensee, Hans-Georg
    Jung, Gundram
    Handgretinger, Rupert
    Lang, Peter
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [46] Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Davies, Stella M.
    Borowitz, Michael J.
    Rosner, Gary L.
    Ritz, Kristin
    Devidas, Meenakshi
    Winick, Naomi
    Martin, Paul L.
    Bowman, Paul
    Elliott, James
    Willman, Cheryl
    Das, Soma
    Cook, Edwin H.
    Relling, Mary V.
    BLOOD, 2008, 111 (06) : 2984 - 2990
  • [47] Considerations for monitoring minimal residual disease using immunoglobulin clonality in patients with precursor B-cell lymphoblastic leukemia
    Jo, Irene
    Chung, Nack-Gyun
    Lee, Seok
    Kwon, Ahlm
    Kim, Jiyeon
    Choi, Hayoung
    Jang, Woori
    Kim, Seongkoo
    Lee, Jae Wook
    Yoon, Jae-Ho
    Cho, Bin
    Han, Kyungja
    Kim, Yonggoo
    Kim, Myungshin
    CLINICA CHIMICA ACTA, 2019, 488 : 81 - 89
  • [48] LONG-TERM FOLLOW-UP OF PATIENTS WITH HYPERTENSIVE DISEASE TREATED WITH GUANETHIDINE
    LEWIS, JA
    KAVELMAN, DA
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1963, 88 (20) : 1010 - &
  • [49] Long-term follow-up of acute lymphoblastic leukemia in young children treated by the SCMC-ALL-2009 protocol
    Liu, Kangkang
    Chu, Jinhua
    Dai, Yu
    Jiang, Aoshuang
    Yang, Linhai
    Xie, Zhiwei
    Zhang, Kunlong
    Tu, Songji
    Cai, Huaju
    Wu, Zhengyu
    Wang, Ningling
    LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 2850 - 2858
  • [50] Evaluation of kidney damage in patients with acute lymphoblastic leukemia in long-term follow-up:: Value of renal scan
    Yetgin, S
    Olgar, S
    Aras, T
    Çetin, M
    Düzova, A
    Belylergil, V
    Akhan, O
    Oguz, O
    Saraçbasi, O
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 77 (02) : 132 - 139
12345